49 related articles for article (PubMed ID: 25675125)
1. Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.
Seal B; Sullivan SD; Ramsey S; Asche CV; Shermock KM; Sarma S; Zagadailov E; Farrelly E; Eaddy M
Future Oncol; 2015; 11(3):439-47. PubMed ID: 25675125
[TBL] [Abstract][Full Text] [Related]
2. Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain.
Bosch X; Sanclemente-Ansó C; Escoda O; Monclús E; Franco-Vanegas J; Moreno P; Guerra-García M; Guasch N; López-Soto A
BMC Cancer; 2018 Mar; 18(1):276. PubMed ID: 29530002
[TBL] [Abstract][Full Text] [Related]
3. Estimating the Direct Medical Outpatient Costs of Diagnosis and Treatment of Trichomoniasis Among Commercially Insured Patients in the United States, 2016 to 2018.
Kumar S; Chesson H; Gift TL
Sex Transm Dis; 2021 Mar; 48(3):e45-e47. PubMed ID: 32810026
[TBL] [Abstract][Full Text] [Related]
4. Traumatic Brain Injury: Patient Characteristics, Hospital Costs and Trends Over Time.
Patel PA; Mallow PJ; Vassar M; Rizzo JA; Pandya BJ; Kruzikas DT
J Health Econ Outcomes Res; 2015; 2(2):108-118. PubMed ID: 37663583
[No Abstract] [Full Text] [Related]
5. Patients' preference regarding inpatient versus outpatient setting - A systematic review.
Schneeberger AR; Werthmueller S; Barco S; Heuss SC
Int J Health Plann Manage; 2023 Sep; 38(5):1409-1419. PubMed ID: 37293696
[TBL] [Abstract][Full Text] [Related]
6. Non-face-to-face care management and service utilization in patients with diabetes.
Stoecker C; Nauman E; Bazzano AN; Price-Haywood EG; Yoshida Y; Shi L
Am J Manag Care; 2023 Aug; 29(8):417-422. PubMed ID: 37616148
[TBL] [Abstract][Full Text] [Related]
7. [Initiative for a shift from inpatient to outpatient treatment].
Volkmer B
Urologie; 2023 Sep; 62(9):898-902. PubMed ID: 37526711
[TBL] [Abstract][Full Text] [Related]
8. Postabsorptive muscle protein synthesis is higher in outpatients as compared to inpatients.
Reidy PT; Borack MS; Dickinson JM; Carroll CC; Burd NA; Drummond MJ; Fry CS; Lambert BS; Gundermann DM; Glynn EL; Markofski MM; Timmerman KL; Moro T; Volpi E; Trappe S; Trappe TA; Harber MP; Rasmussen BB
Am J Physiol Endocrinol Metab; 2023 Aug; 325(2):E113-E118. PubMed ID: 37315157
[TBL] [Abstract][Full Text] [Related]
9. Inpatient hospital costs and length of stay for the treatment of affective and somatoform disorders - evidence from Germany.
Romeyke T; Scheuer HC; Stummer H
Risk Manag Healthc Policy; 2014; 7():245-52. PubMed ID: 25506252
[TBL] [Abstract][Full Text] [Related]
10. Safely Shifting MRIs for Seizure Evaluation to the Outpatient Setting.
Shuster B; Switzer BE; Krishnasamy M; Garimella R; Vu T; Tierney D; Port C
Hosp Pediatr; 2023 Dec; 13(12):1077-1086. PubMed ID: 37960877
[TBL] [Abstract][Full Text] [Related]
11. Costs of malaria treatment in the United States.
Park J; Joo H; Maskery BA; Alpern JD; Weinberg M; Stauffer WM
J Travel Med; 2023 May; 30(3):. PubMed ID: 36718673
[TBL] [Abstract][Full Text] [Related]
12. Split Hospitalization as an Inpatient Care Proposal for Severe Alcohol-Use-Disorder: Considering Hospitalization as a Transition Towards Recovery.
Germeau N; de Timary P
Psychiatr Danub; 2023 Oct; 35(Suppl 2):336-340. PubMed ID: 37800252
[TBL] [Abstract][Full Text] [Related]
13. Systemic therapy for the treatment of hormone-sensitive metastatic prostate cancer: from intermittent androgen deprivation therapy to chemotherapy.
Liaw BC; Shevach J; Oh WK
Curr Urol Rep; 2015 Mar; 16(3):13. PubMed ID: 25677235
[TBL] [Abstract][Full Text] [Related]
14. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
Hoffman RM; Koyama T; Albertsen PC; Barry MJ; Daskivich TJ; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Potosky AL; Penson DF
J Gen Intern Med; 2015 Jul; 30(7):924-34. PubMed ID: 25678374
[TBL] [Abstract][Full Text] [Related]
15. Management of metastatic hormone-sensitive prostate cancer.
Bernard B; Sweeney CJ
Curr Urol Rep; 2015 Mar; 16(3):14. PubMed ID: 25677237
[TBL] [Abstract][Full Text] [Related]
16. The role of intermittent androgen deprivation therapy in the management of biochemically recurrent or metastatic prostate cancer.
Jaswal J; Crook J
Curr Urol Rep; 2015 Mar; 16(3):11. PubMed ID: 25677230
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of prostate cancer screening: a systematic review.
Lao C; Brown C; Rouse P; Edlin R; Lawrenson R
Future Oncol; 2015; 11(3):467-77. PubMed ID: 25675126
[TBL] [Abstract][Full Text] [Related]
18. A urine-based methylation signature for risk stratification within low-risk prostate cancer.
Jatkoe TA; Karnes RJ; Freedland SJ; Wang Y; Le A; Baden J
Br J Cancer; 2015 Mar; 112(5):802-8. PubMed ID: 25695483
[TBL] [Abstract][Full Text] [Related]
19. A review of rectal toxicity following permanent low dose-rate prostate brachytherapy and the potential value of biodegradable rectal spacers.
Schutzer ME; Orio PF; Biagioli MC; Asher DA; Lomas H; Moghanaki D
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):96-103. PubMed ID: 25687401
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer.
Sah BR; Burger IA; Schibli R; Friebe M; Dinkelborg L; Graham K; Borkowski S; Bacher-Stier C; Valencia R; Srinivasan A; Hany TF; Mu L; Wild PJ; Schaefer NG
J Nucl Med; 2015 Mar; 56(3):372-8. PubMed ID: 25678494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
